Gilead Sciences Inc (GILD)
Industry Drug Manufacturers - General
This stock can be held in an Investment ISA and an Investment Account
Sell
$119.53
Buy
$120.50
$-2.81 (-2.28%)
Prices updated at 13 Dec 2025, 00:59 EST
| Prices minimum 15 mins delay
Prices in USD
Gilead Sciences Inc is a biopharmaceutical company that discovers, develops and commercializes new medicines in areas of unmet medical need. Its products target a number of areas, such as HIV, liver diseases, cardiovascular and other diseases.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Profit margins
Valuation
Profit margins data table
Year | Gross margin (%) |
|---|---|
| 2024 | 78.26 |
| 2023 | 76.04 |
| 2022 | 79.26 |
| 2021 | 75.82 |
| 2020 | 81.48 |
| 2019 | 79.18 |
| 2018 | 78.07 |
| 2017 | 83.26 |
| 2016 | 85.98 |
| 2015 | 87.73 |
Valuation data table
Year | Price / Sales |
|---|---|
| 2025 | 5.22 |
| 2024 | 4.08 |
| 2023 | 3.73 |
| 2022 | 3.99 |
| 2021 | 3.35 |
| 2020 | 3.17 |
| 2019 | 3.72 |
| 2018 | 3.69 |
| 2017 | 3.44 |
| 2016 | 3.16 |
| 2015 | 5.00 |
Price/Forward earnings (YTD)
13.70
Returns
Debt profile
Returns data table
Year | Return on assets (%) |
|---|---|
| 2024 | 0.79 |
| 2023 | 9.04 |
| 2022 | 7.00 |
| 2021 | 9.13 |
| 2020 | 0.19 |
| 2019 | 8.60 |
| 2018 | 8.14 |
| 2017 | 7.27 |
| 2016 | 24.84 |
| 2015 | 41.93 |
Debt profile data table
| Year | Financial leverage |
|---|---|
| 2024 | 3.05 |
| 2023 | 2.72 |
| 2022 | 2.97 |
| 2021 | 3.23 |
| 2020 | 3.76 |
| 2019 | 2.74 |
| 2018 | 2.98 |
| 2017 | 3.44 |
| 2016 | 3.02 |
| 2015 | 2.79 |
The figures shown in the Profit Margins table EBITDA column are quoted in the currency of the stock selected.
